-
1
A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
Published 2025-01-01Subjects: Get full text
Article -
2
-
3
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Published 2025-02-01Subjects: Get full text
Article